Scott M. Rocklage
Director, Relypsa Inc.
Companies
- Aprea Therapeutics, Inc.Board member Oct 2, 2019 to Jul 1, 20201
- Cidara TherapeuticsBoard member Apr 14, 2015 to Jun 15, 20182
- Pulmatrix, Inc.Board member Jun 17, 2015 to Feb 25, 20163
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Recent filings
- Aug 7, 2026Sold 52,317 shares at $6.85 of Entrada Therapeutics, Inc.4
- Aug 6, 2026Sold 10,494 shares at $7.00 of Entrada Therapeutics, Inc.4
- Jul 31, 2026Sold 1,718 shares at $6.85 of Entrada Therapeutics, Inc.5
- Jul 30, 2026Sold 114,756 shares at $6.93 of Entrada Therapeutics, Inc.5
- Aug 22, 2025Sold 6,470 shares at $3.42 of Skye Bioscience, Inc.6
- Aug 22, 2025Sold 163,979 shares at $3.42 of Skye Bioscience, Inc.6
- Aug 21, 2025Sold 2,314 shares at $3.57 of Skye Bioscience, Inc.6
- Aug 21, 2025Sold 58,642 shares at $3.57 of Skye Bioscience, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARCidara Therapeutics, Board member
- 3SEC EDGARPulmatrix, Inc., Board member
- 4SEC EDGARForm 4 filed Aug 10, 2026
- 5SEC EDGARForm 4 filed Aug 3, 2026
- 6SEC EDGARForm 4 filed Aug 22, 2025